5.77

2.45% -0.145

Champions Oncology Inc (CSBR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$5.915

Aprire:

$5.65

Volume 24 ore:

2,911

Relative Volume:

0.38

Capitalizzazione di mercato:

$80.13M

Reddito:

$57.94M

Utile/perdita netta:

$-2.34M

Rapporto P/E:

-34.63

EPS:

-0.1666

Flusso di cassa netto:

$3.82M

1 W Prestazione:

-0.35%

1M Prestazione:

-4.94%

6M Prestazione:

-9.70%

1 anno Prestazione:

-34.80%

Intervallo 1D:

$5.65

$6.02

Intervallo di 1 settimana:

$5.65

$6.02

Portata 52W:

$5.50

$9.6299

Champions Oncology Inc Stock (CSBR) Company Profile

Nome

Champions Oncology Inc

Settore

Healthcare (1116)

Industria

Biotechnology (624)

Telefono

410-369-0365

Indirizzo

855 N. WOLFE STREET, BALTIMORE, NJ

Dipendente

306

Cinguettio

@ChampsOnco

Prossima data di guadagno

2026-03-12

Ultimi documenti SEC

CSBR's Discussions on Twitter

Compare CSBR vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CSBR Champions Oncology Inc	5.77	80.13M	57.94M	-2.34M	3.82M	-0.1666
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-09-12	Aggiornamento	Craig Hallum	Hold → Buy
2019-11-18	Iniziato	The Benchmark Company	Speculative Buy

Champions Oncology Inc Borsa (CSBR) Ultime notizie

Apr 05, 2026

Understanding Momentum Shifts in (CSBR) - Stock Traders Daily

Apr 05, 2026

Performance Recap: What is Champions Oncology Incs debt to equity ratioMarket Risk Summary & Community Trade Idea Sharing - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

CSBR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Champions Oncology, Inc.Common Stock (NQ: CSBR - The Chronicle-Journal

Apr 03, 2026

Apr 02, 2026

Market Review: How correlated is Champions Oncology Inc to the S P5002026 Setups & Long-Term Capital Growth Strategies - baoquankhu1.vn

Apr 02, 2026

Apr 01, 2026

CSBR PE Ratio & Valuation, Is CSBR Overvalued - Intellectia AI

Apr 01, 2026

CSBR Should I Buy - Intellectia AI

Apr 01, 2026

Mar 31, 2026

Champions Oncology appoints Brian Alexander to board By Investing.com - Investing.com Australia

Mar 31, 2026

The World's First Agentic CMS Just Got Smarter: Kontent.ai Launches Expert Agents - Via Ritzau

Mar 31, 2026

Mar 30, 2026

Risk Off: How does Champions Oncology Inc compare to its peersLayoff News & Technical Pattern Based Buy Signals - baoquankhu1.vn

Mar 30, 2026

Champions Oncology Adds Director to Advance Data-Driven Strategy - TipRanks

Mar 30, 2026

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy - irw-press.com

Mar 30, 2026

Champ appoints Dr. Brian Alexander to board after Dr. Philip Breitfeld resignation - TradingView

Mar 30, 2026

Brian Alexander joins Champions Oncology (NASDAQ: CSBR) board - stocktitan.net

Mar 30, 2026

Stock Market Recap: Will Champions Oncology Inc benefit from geopolitical trends2026 Bull vs Bear & Safe Entry Momentum Tips - baoquankhu1.vn

Mar 30, 2026

Champions Oncology appoints Brian Alexander to board - Investing.com

Mar 30, 2026

Champions Oncology taps data-focused cancer doctor for board seat - stocktitan.net

Mar 30, 2026

Mandela Dollar ("MUSD") Announced to Promote Mandela's Legacy of Financial Inclusion for Underserved Communities Across the World - STT Info

Mar 30, 2026

Safe Staffing Requires New Models of Care, Not Just More Clinicians, Says Global Taskforce - STT Info

Mar 30, 2026

Mar 29, 2026

Champions Oncology, Inc. Appoints Brian Alexander to Board of Directors - marketscreener.com

Mar 29, 2026

MAIA PE Ratio & Valuation, Is MAIA Overvalued - Intellectia AI

Mar 29, 2026

Targets Report: Is Vinci Partners Investments Ltd a good ESG investment2026 Reactions & Verified Trade Idea Suggestions - baoquankhu1.vn

Mar 29, 2026

Mar 28, 2026

New Highs: Is Champions Oncology Inc showing insider buying2026 Fundamental Recap & Risk Controlled Daily Plans - baoquankhu1.vn

Mar 28, 2026

Valuation Update: Is Champions Oncology Inc stock trending bullishWeekly Stock Report & Risk Controlled Daily Plans - baoquankhu1.vn

Mar 28, 2026

Mar 25, 2026

Avoiding Lag: Real-Time Signals in (CSBR) Movement - Stock Traders Daily

Mar 25, 2026

Mar 24, 2026

Champions Oncology outlines full year revenue growth and positive adjusted EBITDA targets amid early traction in data business - MSN

Mar 24, 2026

IPO Launch: Is FOXXW stock undervalued right nowTrade Risk Assessment & Risk Controlled Daily Trade Plans - baoquankhu1.vn

Mar 24, 2026

Mar 23, 2026

Strengthening Preclinical Packages for FDA Radiopharmaceutical Approval - PharmTech.com

Mar 23, 2026

Mar 22, 2026

Nasdaq Moves: What is the Moat Score of Champions Oncology Inc2026 Price Action Summary & Verified Chart Pattern Signals - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

Trading Action: How does Champions Oncology Inc score in quality rankingsEarnings Risk Summary & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Mar 21, 2026

Nasdaq Moves: How correlated is Champions Oncology Inc to the S P5002026 Gainers & Low Volatility Stock Recommendations - baoquankhu1.vn

Mar 21, 2026

Guidance Update: Will Champions Oncology Inc benefit from geopolitical trends2026 Snapshot & Verified Entry Point Signals - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

S P Trends: Is Champions Oncology Inc benefiting from innovation trendsMarket Risk Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn

Mar 20, 2026

Mar 18, 2026